Literature DB >> 24996822

Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity.

Guo-Yun Chen1, Nicholas K Brown2, Pan Zheng3, Yang Liu4.   

Abstract

Siglec-G/10 is broadly expressed on B cells, dendritic cells and macrophage subsets. It binds strongly to CD24, a small glycosyl-phosphatidylinositol-anchored sialoprotein, in a sialylation-dependent manner. Targeted mutation of Siglecg dramatically elevates the level of natural IgM antibodies and its producer, B1 B cells. Incorporation of Siglec-G ligands to both T-dependent and T-independent immunogens reduces antibody production and induces B-cell tolerance to subsequent antigen challenges. By interacting with CD24, Siglec-G suppresses inflammatory responses to danger (damage)-associated molecular patterns, such as heat-shock proteins and high mobility group protein 1, but not to Toll-like receptor ligands. By a CD24-independent mechanism, Siglec-G has been shown to associate with Cbl to cause degradation of retinoic acid-inducible gene 1 and reduce production of type I interferon in response to RNA virus infection. The negative regulation by Siglec-G/10 may provide a mechanism for the host to discriminate between infectious nonself and noninfectious self, as envisioned by the late Dr. Charles A. Janeway.
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  DAMP; PAMP; Siglec-G; self–nonself

Mesh:

Substances:

Year:  2014        PMID: 24996822      PMCID: PMC4116048          DOI: 10.1093/glycob/cwu068

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  62 in total

1.  Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor.

Authors:  J Munday; S Kerr; J Ni; A L Cornish; J Q Zhang; G Nicoll; H Floyd; M G Mattei; P Moore; D Liu; P R Crocker
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

Review 2.  Siglecs in the immune system.

Authors:  P R Crocker; A Varki
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

3.  Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.

Authors:  Fabian Pfrengle; Matthew S Macauley; Norihito Kawasaki; James C Paulson
Journal:  J Immunol       Date:  2013-07-08       Impact factor: 5.422

4.  B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXR.

Authors:  Stephanie C Casey; Edward L Nelson; Gina M Turco; Matthew R Janes; David A Fruman; Bruce Blumberg
Journal:  Mol Endocrinol       Date:  2011-03-24

5.  A hypomorphic IgH-chain allele affects development of B-cell subsets and favours receptor editing.

Authors:  Sven Brenner; Diana Drewel; Thomas Steinbart; Florian Weisel; Eric Härtel; Sonja Pötzsch; Heike Welzel; Andreas Brandl; Philipp Yu; Geert C Mudde; Astrid Schweizer; Lars Nitschke; Thomas H Winkler
Journal:  EMBO J       Date:  2011-05-27       Impact factor: 11.598

Review 6.  Siglecs and immune regulation.

Authors:  Shiv Pillai; Ilka Arun Netravali; Annaiah Cariappa; Hamid Mattoo
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

Review 7.  CD22 and Siglec-G in B cell function and tolerance.

Authors:  Jonathan C Poe; Thomas F Tedder
Journal:  Trends Immunol       Date:  2012-06-05       Impact factor: 16.687

8.  Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b β2-integrin-dependent signaling.

Authors:  Sarah J McMillan; Ritu S Sharma; Emma J McKenzie; Hannah E Richards; Jiquan Zhang; Alan Prescott; Paul R Crocker
Journal:  Blood       Date:  2013-01-11       Impact factor: 22.113

9.  Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation.

Authors:  Weilin Chen; Chaofeng Han; Bin Xie; Xiang Hu; Qian Yu; Liyun Shi; Qingqing Wang; Dongling Li; Jianli Wang; Pan Zheng; Yang Liu; Xuetao Cao
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

10.  T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10.

Authors:  Esther Bandala-Sanchez; Yuxia Zhang; Simone Reinwald; James A Dromey; Bo-Han Lee; Junyan Qian; Ralph M Böhmer; Leonard C Harrison
Journal:  Nat Immunol       Date:  2013-05-19       Impact factor: 25.606

View more
  29 in total

1.  Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal-maternal interface.

Authors:  Marei Sammar; Monika Siwetz; Hamutal Meiri; Viktor Fleming; Peter Altevogt; Berthold Huppertz
Journal:  Histochem Cell Biol       Date:  2016-12-23       Impact factor: 4.304

Review 2.  Neutrophil migration in infection and wound repair: going forward in reverse.

Authors:  Sofia de Oliveira; Emily E Rosowski; Anna Huttenlocher
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

Review 3.  Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation.

Authors:  Bruce S Bochner; Nives Zimmermann
Journal:  J Allergy Clin Immunol       Date:  2015-01-13       Impact factor: 10.793

Review 4.  Chemo- and mechanosensing by dendritic cells facilitate antigen surveillance in the spleen.

Authors:  Dan Liu; Lihui Duan; Jason G Cyster
Journal:  Immunol Rev       Date:  2022-03       Impact factor: 12.988

Review 5.  Innate Immune Responses to Fungal Allergens.

Authors:  Jay M Portnoy; P Brock Williams; Charles S Barnes
Journal:  Curr Allergy Asthma Rep       Date:  2016-09       Impact factor: 4.806

Review 6.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

7.  Induction of Siglec-1 by Endotoxin Tolerance Suppresses the Innate Immune Response by Promoting TGF-β1 Production.

Authors:  Yin Wu; Chao Lan; Dongren Ren; Guo-Yun Chen
Journal:  J Biol Chem       Date:  2016-04-18       Impact factor: 5.157

8.  Siglec-E Negatively Regulates the Activation of TLR4 by Controlling Its Endocytosis.

Authors:  Yin Wu; Dongren Ren; Guo-Yun Chen
Journal:  J Immunol       Date:  2016-09-12       Impact factor: 5.422

9.  Macrophage-Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention.

Authors:  Xuefei Zhou; Xiangrui Liu; Leaf Huang
Journal:  Adv Funct Mater       Date:  2020-11-10       Impact factor: 18.808

10.  Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma.

Authors:  Nan Xiao; Xiaodong Zhu; Kangshuai Li; Yifan Chen; Xuefeng Liu; Bin Xu; Ming Lei; Jiejie Xu; Hui-Chuan Sun
Journal:  Exp Hematol Oncol       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.